| 标题 |
LBA23 Sacituzumab tirumotecan (sac-TMT) vs investigator's choice of chemotherapy (ICC) in previously treated locally advanced or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer (BC): Results from the randomized, multi-center phase III OptiTROP-Breast02 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Y. Fan; H. Li; H. Wang; S. Wang; H. Yu; et al 出版日期:2025-11-20 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)